US Patent 10568875 Atropine pharmaceutical compositions
Patent 10568875 was granted and assigned to Nevakar Llc on February, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 11 Dec, 2023
Golden AI
Edits made to:
Article (+415 characters)
Article
Patent abstract
The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
105688750
Date of Patent
February 25, 2020
0Patent Application Number
162803840
Date Filed
February 20, 2019
0Patent Citations
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
105688750
Date of Patent
February 25, 2020
0Patent Application Number
162803840
Date Filed
February 20, 2019
0Patent Citations
Patent Primary Examiner
Edits on 1 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 10568875 Atropine pharmaceutical compositions
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10568875
Date of patent
February 25, 2020
Patent application number
16280384
Date Filed
February 20, 2019
Patent citations
Patent primary examiner
Find more entities like US Patent 10568875 Atropine pharmaceutical compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
